PROCTER & GAMBLE HEALTH
|
|
BOM : 500126     NSE : PGHL     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Sep 20,2024 |
Price(EOD): ₹ 5,183.70
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 8,604.94 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
PROCTER & GAMBLE HEALTH | 0.5% | -1% | 3.4% |
SUN PHARMACEUTICAL INDUSTRIES | 0.1% | 6.6% | 60.6% |
CIPLA | -1.2% | 3.4% | 32.6% |
DR REDDYS LABORATORIES | -1.4% | -6% | 11.8% |
ZYDUS LIFESCIENCES | -5.4% | -12.8% | 63.3% |
DIVIS LABORATORIES | -0.5% | 11% | 42.5% |
FUNDAMENTAL ANALYSIS OF PROCTER & GAMBLE HEALTH
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF PROCTER & GAMBLE HEALTH
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
42.81
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 200.98 Cr
[Latest Qtr - Jun2024 - Standalone Results ] 15.99
P/B Calculated based on Book Value of Rs 538.24 Cr
[Latest Year - Jun2024 - Standalone Results ] 7.47
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
38% 52% 35% |
SHARE PRICE MOMENTUM OF PROCTER & GAMBLE HEALTH
PROCTER & GAMBLE HEALTH vs SENSEX
DEBT OF PROCTER & GAMBLE HEALTH
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2023 2022 2021 Avg_3yrs |
0 0 0 - |
- - - - |
[Last Annual Data : Jun2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF PROCTER & GAMBLE HEALTH
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF PROCTER & GAMBLE HEALTH
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
12.44% -28.45% -63.6% -63.96% |
-5.74% 6.42% -48.27% -43.73% |
QtrlyTrend |
-4 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
PROCTER & GAMBLE HEALTH related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 500 | 1.1% | 3.4% | 36.8% |
S&P BSE ALLCAP | 1% | 3.3% | 37.9% |
S&P BSE SMALL CAP | -0.1% | 3.2% | 51.3% |
S&P BSE 400 MIDSMALLCAP | -0.1% | 2.8% | 49.1% |
S&P BSE HEALTHCARE | -0.4% | 5.1% | 54.4% |
You may also like the below Video Courses
FAQ about PROCTER & GAMBLE HEALTH
Is PROCTER & GAMBLE HEALTH good for long term investment?
As on Sep 20,2024, the Fundamentals of PROCTER & GAMBLE HEALTH look Strong and hence it may be good for long term investment! See Financial Performance of PROCTER & GAMBLE HEALTH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is PROCTER & GAMBLE HEALTH UnderValued or OverValued?
As on Sep 20,2024, PROCTER & GAMBLE HEALTH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of PROCTER & GAMBLE HEALTH ?
As on Sep 20,2024, the Intrinsic Value of PROCTER & GAMBLE HEALTH is Rs. 3,761.86 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 3,761.86
Fair Value [Median EV / Sales Model] : Rs. 3,415.82
Fair Value [Median Price / Sales Model] : Rs. 3,840.80
Estimated Median Fair Value of PROCTER & GAMBLE HEALTH : Rs. 3,761.86
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.